# Observational Study: Hetrombopag for Platelet Recovery in Haploidentical HSCT

> **NCT07003269** · — · ENROLLING_BY_INVITATION · sponsor: **Haikou Affiliated Hospital of Central South University Xiangya School of Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Thalassemia in Children

## Interventions

- **DRUG:** Hetrombopag

## Key facts

- **NCT ID:** NCT07003269
- **Lead sponsor:** Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07003269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07003269, "Observational Study: Hetrombopag for Platelet Recovery in Haploidentical HSCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07003269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*